International Study of Biofield Therapy

Pain Clinical Trial

Official title:

International Cross-sectional Study on the Effectiveness of Biofield Therapy for the Relief of Various Symptoms

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03994809
• Other study ID #: MOA-004
• Status: Completed
• Start date: January 1, 2008
• Est. completion date: September 30, 2010

Study information

• Verified date: June 2019
• Source: MOA Health Science Foundation
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Participants from 14 different countries received a single session of biofield therapy (Okada Purifying Therapy) lasting 30 minutes or longer from the volunteer practitioners. Before and after the therapy, they reported the severity of physical pain, anxiety/depression, dizziness/palpitation, and overall symptoms. The team compared the effectiveness/safety of biofield therapy between countries and analyzed the factors associated with the outcomes.

Description:

Participants aged 16 or older from 14 different countries (Japan, USA, Argentina, Brazil, Chile, Mexico, Peru, Taiwan, Thai, South Korea, Belgium, France, Portugal, and Spain) received a single session of biofield therapy (Okada Purifying Therapy) lasting 30 minutes or longer from the volunteer practitioners in their country of residence. Before and after the intervention, they reported each severity level of physical pain, anxiety/depression, dizziness/palpitation, and overall symptoms. The team compared the improvement/exacerbation rate of a single session of biofield therapy between the countries, and examined the adjusted odds ratio of the variables associated with the changes in each category of symptoms in a real-world setting.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 12000
• Est. completion date: September 30, 2010
• Est. primary completion date: September 30, 2010
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 16 Years and older

Eligibility

Inclusion Criteria:

1. Individuals who agreed to receive a single session of biofield therapy for 30 minutes or longer from the volunteer investigators.

2. Individuals who were able to self-evaluate the change of their symptoms.

3. Individuals who were competent to answer the questionnaires.

4. Individuals who were aged 16 or older.

Exclusion Criteria:

• no specific exclusion criteria

Related Conditions & MeSH terms

• Depression, Anxiety
• Dizziness
• Pain
• Signs and Symptoms

Intervention

Other:
• Okada Purifying Therapy
The practitioner raises his/her hand forward towards the recipient with the palm directed toward the recipient. The practitioner uses his/her hands alternately during the administration of Okada Purifying Therapy. The distance between the palm and the body is usually 1-2 feet, with each session typically lasting 30 to 60 minutes.

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
MOA Health Science Foundation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	improvement/exacerbation rate of symptoms after a single session of biofield therapy	The Mann-Whitney test was conducted to compare the improvement/exacerbation rates between countries.	Up to one year after all the data were collected.
Primary	adjusted odds ratio of the factors associated with the changes in symptoms	Logistic regression analyses	Up to one year after all the data were collected.